Q5001 HCPCS code: Hospice or home health care provided in patient's home/residence
Q5001 is the HCPCS Level II code for hospice or home health care provided in patient's home/residence. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | Y2 |
| Added | 2007-01-01 |
| Last action effective | 2013-07-01 |
What changed for Q5001
- 2007-01-01: Q5001 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q5001?
Q5001 is the HCPCS Level II code for hospice or home health care provided in patient's home/residence. Short descriptor: "Hospice or home hlth in home".
Does Medicare cover Q5001?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Related Q50 codes
- Q5002 — Hospice or home health care provided in assisted living facility
- Q5003 — Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
- Q5004 — Hospice care provided in skilled nursing facility (snf)
- Q5005 — Hospice care provided in inpatient hospital
- Q5006 — Hospice care provided in inpatient hospice facility
- Q5007 — Hospice care provided in long term care facility
- Q5008 — Hospice care provided in inpatient psychiatric facility
- Q5009 — Hospice or home health care provided in place not otherwise specified (nos)
- Q5010 — Hospice home care provided in a hospice facility
- Q5098 — Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
- Q5099 — Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q5001
- Watch Q5001 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q5001
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.